Related Experiment Videos
Surgical management to avoid severe postreperfusion syndrome: controlled limb reperfusion
1Department of Cardiovascular Surgery, Albert-Ludwigs-University, Freiburg, Germany.
Transplantation Proceedings
|October 1, 1995
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Association Between Sleep Quality and Oxidative Stress in Postoperative Cardiovascular Patients-A Pilot Study.
Journal of sleep research·2026
Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA).
Asian cardiovascular & thoracic annals·2024
Making a Difference: 5 Years of Cardiac Surgery Intersociety Alliance (CSIA).
The Annals of thoracic surgery·2024
Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA).
The Journal of thoracic and cardiovascular surgery·2024
Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA).
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2024
[CARL-Controlled reperfusion of the whole body].
Zeitschrift fur Herz-, Thorax- und Gefasschirurgie·2022
Barth Syndrome and Referral to Heart Transplantation: Single-Center Experience and Literature Review.
Transplantation proceedings·2026
Impact of Bacterial Infections in Adult Heart Transplant Recipients: A Single-Center Experience (2017-2024).
Transplantation proceedings·2026
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026